GLOBAL LIQUIDITY DESK | LONDON FIX: 16:00 GMT | NEW YORK CASH: ACTIVE | RAW ECN SPREAD: 0.0 PIPS | LATENCY: 4.2ms DIRECT
TLS 1.3 256-BIT ENCRYPTED | 24/7 VIP CONCIERGE
Back to Live Wire • Stocks • Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects
Live Signals Terminal
Stocks 📡 Source: MarketWatch
📅 Sep 30, 2026 · 23:35 • 👁️ 3,888 views

Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects

Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects
The pharma giant is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes.
\n